A comprehensive view of Oral Medicines / Supplements. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Global gummy supplement market anticipated to reach US$48.5B by 2028, growing at a CAGR of 14.5% from 2023-2028; growth driven by appeal of gummies, micronutrient deficiencies worldwide, particularly among children and pregnant women

Janssen submits NDA to FDA for approval of single tablet combination therapy of Macitentan and Tadalafil to treat pulmonary arterial hypertension; PAH is a rare blood vessel disorder that constricts small pulmonary arteries, elevates blood pressure

Janssen and Bristol Myers' Milvexian granted FDA fast track designation for all three indications under evaluation in Phase 3 Librexia program; indications include ischemic stroke, acute coronary syndrome and atrial fibrillation

Pfizer’s oral Paxlovid nirmatrelvir and ritonavir COVID-19 treatment receives FDA approval for adult patients at high risk of progression to severe COVID-19; about 14,500 cases of COVID-19 were reported each week as of the end of April 2023

Eli Lilly listed a new US clinical trial to study once-daily oral orforglipron LY3502970 in adults with obesity or overweight with weight-related comorbidities

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count